Cargando…

COVID-19 Vaccine Second-Dose Completion and Interval Between First and Second Doses Among Vaccinated Persons — United States, December 14, 2020−February 14, 2021

Detalles Bibliográficos
Autores principales:	Kriss, Jennifer L., Reynolds, Laura E., Wang, Alice, Stokley, Shannon, Cole, Matthew M., Harris, LaTreace Q., Shaw, Lauren K., Black, Carla L., Singleton, James A., Fitter, David L., Rose, Dale A., Ritchey, Matthew D., Toblin, Robin L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2021
Materias:	Full Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7976616/ https://www.ncbi.nlm.nih.gov/pubmed/33735162 http://dx.doi.org/10.15585/mmwr.mm7011e2

Ejemplares similares

Demographic Characteristics of Persons Vaccinated During the First Month of the COVID-19 Vaccination Program — United States, December 14, 2020–January 14, 2021
por: Painter, Elizabeth M., et al.
Publicado: (2021)

County-Level COVID-19 Vaccination Coverage and Social Vulnerability — United States, December 14, 2020–March 1, 2021
por: Hughes, Michelle M., et al.
Publicado: (2021)

Disparities in COVID-19 Vaccination Coverage Between Urban and Rural Counties — United States, December 14, 2020–April 10, 2021
por: Murthy, Bhavini Patel, et al.
Publicado: (2021)

Demographic and Social Factors Associated with COVID-19 Vaccination Initiation Among Adults Aged ≥65 Years — United States, December 14, 2020–April 10, 2021
por: Whiteman, Ari, et al.
Publicado: (2021)

COVID-19 Vaccination Coverage Among Adults — United States, December 14, 2020–May 22, 2021
por: Diesel, Jill, et al.
Publicado: (2021)

Patterns in COVID-19 Vaccination Coverage, by Social Vulnerability and Urbanicity — United States, December 14, 2020–May 1, 2021
por: Barry, Vaughn, et al.
Publicado: (2021)

COVID-19 Vaccination Coverage Among Adolescents Aged 12–17 Years — United States, December 14, 2020–July 31, 2021
por: Murthy, Bhavini Patel, et al.
Publicado: (2021)

Minority Health Social Vulnerability Index and COVID-19 vaccination coverage — The United States, December 14, 2020–January 31, 2022
por: Saelee, Ryan, et al.
Publicado: (2023)

Disparities in COVID-19 Vaccination Coverage Between Urban and Rural Counties — United States, December 14, 2020–January 31, 2022
por: Saelee, Ryan, et al.
Publicado: (2022)

Factors Associated with Delayed or Missed Second-Dose mRNA COVID-19 Vaccination among Persons >12 Years of Age, United States
por: Meng, Lu, et al.
Publicado: (2022)

COVID-19 Vaccine Initiation and Dose Completion During the SARS-CoV-2 Delta Variant Surge in the United States, December 2020–October 2021
por: Murthy, Neil, et al.
Publicado: (2022)

NACI greenlights second doses, dose splitting of monkeypox vaccine
por: Vogel, Lauren
Publicado: (2022)

VITT and Second Doses of Covid-19 Vaccine
por: Lacy, Joanne, et al.
Publicado: (2021)

Immune Response to Vaccination against COVID-19 at Different Second-Dose Intervals and Their Associations with Metabolic Parameters
por: Szczerbiński, Łukasz, et al.
Publicado: (2023)

Ethical and policy considerations for COVID-19 vaccination modalities: delayed second dose, fractional dose, mixed vaccines
por: Wolff, Jonathan, et al.
Publicado: (2021)

Why some people tolerate the second dose of a vaccine but not the first dose
por: Yu, Yihua Bruce, et al.
Publicado: (2022)

Effect of the interval between birth and second dose of hepatitis B vaccine on perinatal transmission of hepatitis B virus
por: Yang, Tae Un, et al.
Publicado: (2023)

Receipt of First and Second Doses of JYNNEOS Vaccine for Prevention of Monkeypox — United States, May 22–October 10, 2022
por: Kriss, Jennifer L., et al.
Publicado: (2022)

Run 26 - 22nd February 1971, Second part: 14.00-17-00h
por: Bryant, P J
Publicado: (1971)

Importance of vaccine action and availability and epidemic severity for delaying the second vaccine dose
por: Berec, Luděk, et al.
Publicado: (2022)

National Influenza Vaccination Week — December 8–14, 2013
Publicado: (2013)

Predictors for Uptake of Vaccines Offered during the Second Year of Life: Second Dose of Measles-Containing Vaccine and Meningococcal Serogroup A-Containing Vaccine, Ghana, 2020
por: Muhoza, Pierre, et al.
Publicado: (2023)

Immune response to second dose of MMR vaccine in Indian children
por: Gomber, Sunil, et al.
Publicado: (2011)

Efficacy of the Second COVID-19 Vaccine Booster Dose in the Elderly
por: Mattiuzzi, Camilla, et al.
Publicado: (2023)

Safety and reactogenicity of second booster doses for mRNA vaccines
por: Wilder-Smith, Annelies, et al.
Publicado: (2023)

The pros and cons of the second booster dose of the COVID-19 vaccine
por: Mostafavi, Ehsan
Publicado: (2022)

Reply to “How important is the second dose of the COVID-19 mRNA vaccine?”
por: Shaker, Marcus S., et al.
Publicado: (2021)

Cohort experience of second messenger RNA vaccine dose tolerance after an initial-dose reaction
por: Eastman, Jacqueline, et al.
Publicado: (2022)

Booster COVID-19 Vaccinations Among Persons Aged ≥5 Years and Second Booster COVID-19 Vaccinations Among Persons Aged ≥50 Years — United States, August 13, 2021–August 5, 2022
por: Fast, Hannah E., et al.
Publicado: (2022)

ACUTE COPD EXACERBATION AFTER THE SECOND DOSE OF COVID-19 VACCINE
por: DURDEVIC, MOMCILO, et al.
Publicado: (2021)

Evaluation of COVID-19 vaccination strategies with a delayed second dose
por: Moghadas, Seyed M., et al.
Publicado: (2021)

Evaluation of COVID-19 vaccination strategies with a delayed second dose
por: Moghadas, Seyed M., et al.
Publicado: (2021)

How important is the second dose of the COVID-19 mRNA vaccine?
por: Liu, Anne Y.
Publicado: (2021)

Development of High-Grade Sarcoma After Second Dose of Moderna Vaccine
por: Bae, Edward, et al.
Publicado: (2023)

Booster and Additional Primary Dose COVID-19 Vaccinations Among Adults Aged ≥65 Years — United States, August 13, 2021–November 19, 2021
por: Fast, Hannah E., et al.
Publicado: (2021)

The Single or Second Dose
por: Gregg, Rollin R.
Publicado: (1885)

Second International Consensus Study of Antipsychotic Dosing (ICSAD-2)
por: McAdam, Matthew KT, et al.
Publicado: (2023)

Interim Estimates of 2013–14 Seasonal Influenza Vaccine Effectiveness — United States, February 2014
por: Flannery, Brendan, et al.
Publicado: (2014)

17. Assessment of Recombinant Zoster Vaccine Second Dose Completion in the United States
por: Patterson, Brandon J, et al.
Publicado: (2020)

Sudden Sensorineural Hearing Loss Following the Second Dose of COVID-19 Vaccine
por: Tsetsos, Nikolaos, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sm13qol0bm0vi04d25rip9dagt